BCRX

Welcome to the Brand page for “BCRX”, which is offered here for Pharmaceutical research services; pharmaceutical drug development services; medical and scientific research, conducting clinical trials for others; development of pharmaceutical preparations and medicines for the treatment of infectious, viral, inflammatory, immunological, autoimmune, and cardiovascular diseases and disorders; development of pharmaceutical preparations and medicines for the treatment of cancer, cancers of the immune system, t-cell and b-cell leukemias and lymphomas; development of pharmaceutical preparations and medicines for the treatment of influenza, aids, sars, ebola, zika, and west nile virus; development of pharmaceutical preparations and medicines for the treatment of hereditary angioedema, inflammatory bowel diseases, inflammatory connective tissue diseases, and inflammatory skin diseases;.

Its status is currently believed to be active. Its class is unavailable. “BCRX” is believed to be currently owned by “BioCryst Pharmaceuticals, Inc.”